瑞慈醫療(01526.HK)中期經調整EBITDA為2.77億元 同比增長457%
格隆匯8月31日丨瑞慈醫療(01526.HK)公吿,截至2021年6月30日止六個月,公司收入為人民幣10億元,同比增長71.4%;公司擁有人應占利潤為人民幣1050萬元,而2020年同期的公司擁有人應占虧損為人民幣1.64億元;經調整EBITDA為人民幣2.77億元,較2020年同期的經調整EBITDA為人民幣4970萬元增長457.0%。
報吿期內,南通瑞慈醫院共提供228,790人次門診服務(2020年同期,151,984人次),較去年同期增長50.5%,並提供15,136人次住院服務(2020年同期,11,365人次),較去年同期增長33.2%。集團以南通瑞慈醫院的醫療資源為基礎,設立了瑞慈美邸護理院及南通瑞慈血透中心與之形成協同。
於2021年6月30日,護理院入住老人105名(於2020年6月30日:100名),入住率99.1%(於2020年6月30日:94.3%)。截至報吿期間,血透中心提供透析服務8,419次(2020年同期:9,189次),較去年同期下降8.4%。
於2021年6月30日,集團於全國擁有63間體檢中心(截至2020年6月30日:60間),較去年同期增長5.0%,其中2021年1–6月在運營體檢中心數為57間(2020年同期:52間),較去年同期增長9.6%。集團的體檢業務已經覆蓋城市28個,全國佈局主要集中在一線、新一線和二線城市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.